bf/NASDAQ:THRN_icon.jpeg

COM:THORNE

Thorne HealthTech

  • Stock

USD

Last Close

10.20

13/10 20:00

Market Cap

550.63M

Beta: -

Volume Today

84.69K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
27.90M
-
34.54M
23.80%
49.83M
44.27%
average payables
7.69M
-
12.79M
66.35%
21.94M
71.56%
average receivables
3.73M
-
4.08M
9.37%
10.04M
145.99%
book value per share
-2.77
-
-1.82
34.29%
4.31
336.58%
2.75
36.29%
capex per share
-0.08
-
-0.05
33.95%
-0.18
249.72%
-0.34
83.81%
capex to depreciation
-0.63
-
-0.54
14.42%
-1.14
110.26%
-3.07
169.86%
capex to operating cash flow
0.38
-
-0.14
135.62%
-0.56
310.44%
-3.42
513.93%
capex to revenue
-0.03
-
-0.02
40.79%
-0.03
62.90%
-0.08
185.81%
cash per share
0.01
-
0.35
2,619.53%
1.86
437.23%
0.68
63.28%
days of inventory on hand
175.16
-
139.06
20.61%
170.32
22.48%
188.10
10.44%
days payables outstanding
42.23
-
43.06
1.96%
70.14
62.88%
86.59
23.46%
days sales outstanding
17.63
-
6.63
62.40%
11.14
68.00%
23.04
106.87%
debt to assets
0.40
-
0.44
10.56%
0.19
57.99%
0.20
9.68%
debt to equity
-0.40
-
-0.64
58.93%
0.28
143.24%
0.32
17.54%
dividend yield
0.01
-
earnings yield
-0.06
-
-0.01
87.83%
0.06
938.76%
0.08
32.90%
enterprise value
315.14M
-
368.92M
17.07%
152.25M
58.73%
202.52M
33.02%
enterprise value over ebitda
-32.96
-
72.82
320.95%
9.71
86.67%
19.65
102.39%
ev to operating cash flow
-41.35
-
21.57
152.15%
16.76
22.28%
38.78
131.40%
ev to sales
3.07
-
2.66
13.31%
0.82
69.15%
0.89
7.73%
free cash flow per share
-0.29
-
0.34
216.05%
0.15
56.34%
-0.24
263.66%
free cash flow yield
-0.04
-
0.04
216.05%
0.02
46.92%
-0.07
379.97%
graham net net
-5.21
-
-3.88
25.53%
0.69
117.70%
-0.13
119.25%
graham number
5.33
-
1.51
71.72%
6.09
304.00%
4.29
29.65%
income quality
0.42
-
-4.33
1,134.20%
1.33
130.67%
0.35
73.65%
intangibles to total assets
0.23
-
0.19
16.10%
0.12
37.23%
0.14
15.59%
interest coverage
-34.22
-
0.68
102.00%
21.68
3,065.76%
208.19
860.48%
interest debt per share
1.13
-
1.19
5.67%
1.21
1.49%
0.89
26.09%
inventory turnover
2.08
-
2.62
25.96%
2.14
18.35%
1.94
9.45%
invested capital
-0.40
-
-0.64
58.93%
0.28
143.24%
0.32
17.54%
market cap
275.02M
-
332.88M
21.04%
170.64M
48.74%
191.51M
12.23%
net current asset value
-174.01M
-
-155.60M
10.58%
44.29M
128.47%
33.47M
24.44%
net debt to ebitda
-4.20
-
7.11
269.55%
-1.17
116.48%
1.07
191.10%
net income per share
-0.46
-
-0.06
87.83%
0.38
789.90%
0.30
22.32%
operating cash flow per share
-0.21
-
0.39
285.46%
0.33
14.80%
0.10
70.06%
payables turnover
8.64
-
8.48
1.93%
5.20
38.60%
4.22
19.00%
receivables turnover
20.70
-
55.06
165.96%
32.78
40.48%
15.84
51.66%
research and ddevelopement to revenue
0.04
-
0.03
19.75%
0.03
5.00%
0.03
1.30%
return on tangible assets
-0.21
-
-0.03
87.70%
0.07
360.36%
0.08
16.25%
revenue per share
2.81
-
3.14
11.56%
6.74
114.68%
4.34
35.69%
roe
0.16
-
0.03
81.48%
0.09
191.61%
0.11
21.93%
roic
0.43
-
0.54
26.66%
0.05
90.53%
0.05
8.30%
sales general and administrative to revenue
0.30
-
0.33
11.48%
shareholders equity per share
-2.77
-
-1.82
34.29%
4.31
336.58%
2.75
36.29%
stock based compensation to revenue
0.12
-
0.07
39.20%
0.02
66.09%
0.05
101.59%
tangible asset value
-129.93M
-
-108.91M
16.18%
97.30M
189.34%
114.78M
17.97%
tangible book value per share
-3.57
-
-2.47
30.75%
3.54
243.35%
2.18
38.56%
working capital
1.38M
-
30.65M
2,123.11%
75.52M
146.41%
77.06M
2.04%

All numbers in USD (except ratios and percentages)